Create an account, provide basic information, and schedule your online consultation with a licensed holistic health doctor.
Use our secure telemedicine video platform to discuss your health concerns from the comfort of your home.
After your consultation, your doctor will create a personalized treatment plan based on your needs.
Our care team will explain all the medication options and help you make the right decision for your weight loss goals.
Rybelsus is approved by the FDA for type 2 diabetes
For best results, take Rybelsus on an empty stomach in the morning, at least 30 minutes before your first meal. This helps ensure the medication is absorbed properly.
Most people start on a low dose, typically 3 mg once daily, and then gradually increase to a dose of 7 mg or 14 mg, depending on how the body responds. Your healthcare provider will closely monitor your progress and adjust your dose as needed.
3 mg taken orally once a day for 30 days. Increase to 7 mg taken orally once a day.
7 to 14 mg orally once a day.
14 mg/day (taking two 7 mg tablets to achieve a 14 mg dose is not recommended).
RYBELSUS® should be kept between 68 and 77 degrees Fahrenheit. Until you’re ready to take a tablet, keep your RYBELSUS® tablets in the closed bottle.
Do not use a pill organizer or other container to store RYBELSUS® tablets. The effectiveness of RYBELSUS® may be diminished if the tablets are stored in a different container or are altered in form before being taken.
Risk of thyroid C−cell tumors
Not everyone experiences them, and many find that initial side effects lessen over time as the body adjusts to the medication.
These side effects are usually manageable, and your healthcare provider can suggest ways to reduce discomfort.
Severe side effects like hypoglycemia (low blood sugar) are rare but may be a concern if Rybelsus is combined with certain other diabetes medications. For this reason, work with your provider to ensure a safe medication regimen.
If you’re feeling serious side effects (see above), call your healthcare provider. You can also report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
A GLP-1 receptor agonist that helps with weight loss by reducing appetite, slowing digestion, and improving metabolic health.
A tirzepatide-based medication designed specifically for weight loss, offering enhanced appetite control and metabolic improvements. Approved by the FDA for weight loss.
A dual-acting GLP-1 and GIP receptor agonist that promotes weight loss by suppressing appetite and improving metabolic function.
An injectable medication with tirzepatide that targets diabetes management and significant weight reduction as a secondary benefit.
An injectable medication containing semaglutide, primarily used for diabetes but effective for weight loss by decreasing hunger and calorie intake.
A higher-dose semaglutide injection approved specifically for weight loss, helping patients achieve significant and sustained results. Approved by the FDA for weight loss.
A combination of naltrexone and bupropion that addresses hunger and cravings, offering a dual-action approach to weight management.
Rybelsus is an oral medication containing Semaglutide, used to manage type 2 diabetes and support weight loss in some cases. **This medication is FDA-approved for [Type 2 Diabetes], and may be prescribed off-label for weight loss by a licensed medical provider.**
Rybelsus mimics the GLP-1 hormone, reducing appetite, slowing digestion, and regulating blood sugar levels.
The starting dose is usually 3 mg once daily for the first month, gradually increasing to 7 mg or 14 mg as directed by your doctor.
Rybelsus may aid in weight loss as a secondary benefit, particularly in individuals with type 2 diabetes. ****This medication is FDA-approved for [Type 2 Diabetes], and may be prescribed off-label for weight loss by a licensed medical provider.**
Common side effects include nausea, diarrhea, vomiting, decreased appetite, and stomach pain.